This inventor holds 5 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Medimmune Limited, Humabs Biomed Sa, Medlmmune Limited. Active years: 2018-2024.
Company Filing History:
4 out of 546 
2 out of 38 
1 out of 6 Years Active: 2018-2024
Title: Chew-shun Chang: Innovator in Antibody Research
Introduction
Chew-shun Chang is a notable inventor based in Gaithersburg, MD (US), recognized for his contributions to the field of antibody research. With a total of five patents to his name, he has made significant strides in developing innovative solutions for medical challenges.
Latest Patents
Among his latest patents is the development of Anti-O1 antibodies and their uses. This patent provides binding proteins, such as antibodies or antigen-binding fragments, that specifically target O1 and induce opsonophagocytic killing. The disclosure also outlines methods for reducing, treating, or preventing infections in subjects by administering these O1 binding proteins. Another patent focuses on antibodies and antigen-binding fragments directed against surface determinant antigens and secreted toxins, offering methods for detection, diagnosis, and treatment using these innovative proteins.
Career Highlights
Chew-shun Chang has worked with prominent companies in the biotechnology sector, including MedImmune Limited and Humabs Biomed SA. His work in these organizations has contributed to advancements in therapeutic antibody development and infectious disease treatment.
Collaborations
Throughout his career, Chang has collaborated with esteemed colleagues, including Christine Tkaczyk and Partha S Chowdhury. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.
Conclusion
Chew-shun Chang's work in antibody research exemplifies the impact of innovation in medicine. His patents and collaborations highlight his commitment to advancing healthcare solutions through scientific discovery.